Non-exclusive discount agreement for Oxybutynin (PFT dosage form)
Non-exclusive discount agreement for the active ingredient Oxybutynin (PFT dosage form only), ATC G04BD04: Contract period from 01.09.2026 to 31.08.2028, with one extension option of 1x12 months. Any pharmaceutical company can conclude a framework agreement at any time under the same conditions. Required documents include a letter of offer, acceptance of the contractual terms and discounts, and completed Annexes 1 and 2, in which the medicines containing the active ingredient must be entered. Documents must be submitted via email to openhouse@dak.de, with Annex 2 to be sent as an Excel file. For a contract start on 01.09.2026, documents must be submitted by the 5th of the preceding month. Later entries are possible at any time; for an entry on the 1st or 15th of the following month, documents must be submitted by the 5th of the preceding month. further items as per the tender documents.
CONTRACTING AUTHORITY
Name
DAK-Gesundheit
City
Hamburg
Country
DE
CLASSIFICATION
Procedure Type
Open Procedure
Contract Type
Supplies
Main CPV
33600000, Pharmaceutical products.
ADDITIONAL DETAILS
EU Funded
Yes
Suitable for SMEs
No
Electronic Submission
Required
Legal Basis
32014L0024
DEADLINES & TIMELINE
Submission Deadline
1085 days remaining(LOT-0001)
Published